According to IMARC Group latest report titled “Immunodiagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on immunodiagnostic market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global immunodiagnostics market size reached US$ 17.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.2 Billion by 2028, exhibiting a growth rate (CAGR) of 7.72% during 2023-2028.
Immunodiagnostics represents an in-vitro diagnostic technology that uses antigen-antibody reaction for the detection of infectious and chronic diseases. It usually involves the utilization of radiological, fluorescent or color-forming enzymes and probes to identify antibodies that help in improving the targeting range to determine disease progression. Immunodiagnostics also comprises several reagents, instruments, and software-based solutions for enzyme-linked immunosorbent assay, radioimmunoassay, chemiluminescence, rapid testing, etc. This technology is widely utilized for diagnosing autoimmune, respiratory, endocrine, and oncological disorders. Consequently, it finds extensive applications in clinical laboratories, hospitals, research and academic institutes, etc., across the globe.
Request to Get the Sample Report: https://www.imarcgroup.com/immunodiagnostics-market/requestsample
Market Trends:
The growing prevalence of chronic diseases and infections and the expanding geriatric population are primarily driving the immunodiagnostics market. Additionally, the introduction of advanced point-of-care testing (POCT) systems that offer enhanced diagnostic facilities for sepsis, acute cardiac infractions, and other medical disorders with higher mortality rates is further bolstering the market growth. Besides this, the rising consumer awareness towards the available treatment alternatives for hepatitis B, diabetes, and cancer is propelling the demand for immunodiagnostics kits, assays, and analyzers, which is acting as another significant growth-inducing factor. Moreover, continuous technological advancements, including the development of next-generation immunodiagnostics platforms, are positively influencing the global market. Apart from this, the increasing improvements in the healthcare infrastructures by public and private agencies are also stimulating market growth. Furthermore, the inflating need for personalized medicines and extensive R&D activities in the field of forensic science are projected to fuel the immunodiagnostics market over the forecasted period.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/immunodiagnostics-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories
- Arkray Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A.
- Hoffmann-La Roche AG
- Immunodiagnostic Systems Holdings PLC
- Johnson & Johnson
- Siemens AG
- Sysmex Corporation
- Thermo Fisher Scientific Inc
Immunodiagnostics Market Segmentation:
Our report has categorized the market based on region, product, technology, application and end use industry.
Breakup by Product:
- Reagents
- Instruments
- Software and Services
Breakup by Technology:
- Enzyme-Linked Immunosorbent Assay
- Chemiluminescence Immunoassay
- Fluorescent Immunoassay
- Radioimmunoassay
- Rapid Test
- Others
Breakup by Application:
- Infectious Diseases
- Oncology and Endocrinology
- Hepatitis and Retrovirus
- Bone and Mineral
- Autoimmunity
- Cardiac Biomarker
- Others
Breakup by End User:
- Hospitals
- Clinical Laboratories
- Academic and Research Centers
- Pharmaceutical and Biotechnology Industry
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Author
